The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ARWR FINANCIAL STATEMENTS

Arrowhead Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

ARWRArrowhead Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-500 M0500 M1 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue669.5 M $Gross Profit669.5 M $ · 100%Operating Income-226.4 M $ · -34%Pre-tax Income-252.1 M $ · -38%Net Income to Owners-320 M $ · -48%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue669.5 M $+12.2%
Gross Profit669.5 M $+17.9%
Operating Income-226.4 M $—
EBITDA-140.3 M $—
Net Income to Owners-320 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets2.1 B
  • Equity465.5 M $22%
  • Current Liabilities283.3 M $13%
  • Long-term Liabilities1.4 B $65%

Key Figures

YoY change
Total Assets2.1 B $+53.0%
Total Liabilities1.6 B $+91.2%
Total Equity465.5 M $-10.9%
Cash & ST Investments1.6 B $+77.9%
Total Debt864.1 M $+21.1%
Net Debt809.3 M $+38.7%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-500 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-750 M-500 M-250 M0-59.1 M $Operating-801.7 M $Investing784.2 M $Financing-76.6 M $Net Change

Key Figures

YoY change
Operating Cash Flow-59.1 M $-370.3%
Capital Expenditures16.1 M $-59.3%
Free Cash Flow-75.1 M $—
Dividends Paid3.1 M $—

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ARWR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.